Speaker
Head of Neurodegeneration, Novartis
Sophie Parmentier-Batteur, Head of Neurodegeneration at Novartis, is speaking at 8th CNS Drug Delivery Summit (Boston, United States of America, 1–3 Dec 2026) in the session “Fireside Chat: Building the Next Generation of CNS Pipelines Through Brain Delivery & Modality Innovation”.
1–3 Dec 2026Boston, United States of America
President & Chief Executive Officer, ArmaGen & JCR Pharmaceuticals
Global Director, Research & Technology Search & Evaluation, Daiichi Sankyo
Head of Device Clinical, Biogen
Director, Neuromuscular Research, Dyne Therapeutics
Executive Director, Drug Delivery & Devices DDCS, Eli Lilly
Head of IDU Device Development & Manufacturing, Biogen
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Sophie Parmentier-Batteur, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].